Clinical Trial Update: Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial of bosentan for inoperable chronic thromboembolic pulmonary hypertension indicates the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Actelion | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 3 | Status: COMPLETED